Comorbilidad psiquiátrica en jóvenes-adultos consumidores de cannabis

Aida M Cuenca-Royo, Marta Torrens, Albert Sánchez-Niubó, Josep M Suelves, Antònia Domingo-Salvany

Resumen


Este estudio transversal tiene como objetivo determinar la prevalencia vida
de trastornos psiquiátricos (incluyendo los trastornos por uso de sustancias,
–TUS y los otros trastornos no por uso de sustancias, –No-TUS) entre 289
jóvenes (18-30 años) consumidores regulares de cannabis durante el últi- mo año, reclutados fuera del entorno asistencial en Barcelona. Se adminis- tró la versión española de la Psychiatric Interview for Substance and Mental
Disorders (PRISM). Sólo el 28% de los participantes no presentó ningún
trastorno psiquiátrico, y el 65% tenía algún TUS, el más común relacionado
con el cannabis (62%). Casi el 27% presentó trastornos no-TUS. Una edad
de inicio más temprana en el consumo de alcohol se asoció con la presen- cia de algún TUS. Haber consumido un número mayor de “porros” en el último mes se asoció con la presencia de trastornos psiquiátricos (TUS y no-TUS). Mientras tres cuartas partes de los pacientes con trastornos no-TUS habían recibido algún tipo de tratamiento, sólo el 28% de las per- sonas con cualquier TUS habían recibido tratamiento. Dada la baja percep- ción de necesidad de tratamiento, se hacen necesarias estrategias de pre- vención y poder ofrecer terapias adaptadas y dirigidas a los consumidores jóvenes de cannabis.


Palabras clave


cannabis; trastornos psiquiátricos; tratamiento; PRISM

Texto completo:

PDF

Referencias


Agosti, V., Nunes, E., & Levin, F. (2002). Rates of psychiatric comorbidity

among U.S. residents with lifetime cannabis dependence. American

Journal of Drug and Alcohol Abuse, 28, 643-652.

Arendt, M. & Munk-Jorgensen, P. (2004). Heavy cannabis users seeking

treatment- prevalence of psychiatric disorders. Social Psychiatry and Psychiatric Epidemiology, 39, 97-105.

Arendt, M., Rosenberg, R., Foldager, L., Perto, G., & Munk-Jorgensen, P.

(2005). Cannabis-induced psychosis and subsequent schizophreniaspectrum disorders: follow-up study of 535 incident cases. British Journal of Psychiatry, 187, 510-515.

Arendt, M., Rosenberg, R., Foldager, L., Perto, G., & Munk-Jorgensen, P.

(2007). Psychopathology among cannabis-dependent treatment seekers and association with later substance abuse treatment. Journal of Substance Abuse Treatment, 32, 113-119.

Arendt, M., Rosenberg, R., Foldager, L., Sher, L., & Munk-Jorgensen, P. (2007). Withdrawal symptoms do not predict relapse among subjects treated for cannabis dependence. American Journal on Addictions, 16, 461-467.

Astals, M., Diaz, L., Domingo-Salvany, A., Martín-Santos, R., Bulbena, A.,

& Torrens, M. (2009). Impact of Co-Occurring Psychiatric Disorders on Retention in a Methadone Maintenance Program: An 18-Month Follow-Up Study. International Journal of Environmental Research and Public Health, 6, 2822-2832.

Barea, J., Benito, A., Mateu, C., Martin, E., Lopez, N., & Haro, G. (2010).

Research on etiological aspects of dual pathology. Adicciones, 22, 15-24.

Casares-Lopez, M. J., Gonzalez-Menendez, A., Bobes-Bascaran, M. T.,

Secades, R., Martinez-Cordero, A., & Bobes, J. (2011). Need for the

assessment of dual diagnosis in prisons. Adicciones, 23, 37-44.

Caspi, A., Moffitt, T. E., Cannon, M., McClay, J., Murray, R., Harrington, H.,

… Craig, I. W. (2005). Moderation of the effect of adolescent-onset cannabis use on adult psychosis by a functional polymorphism in the catechol-O-methyltransferase gene: longitudinal evidence of a gene X environment interaction. Biological Psychiatry, 57, 1117-1127.

Codony, M., Alonso, J., Almansa, J., Vilagut, G., Domingo-Salvany, A.,

Pinto-Meza, A.,… Haro, J. M. (2007). Utilización de los servicios de salud mental en la población general española. Resultados del estudio ESEMeD-España. Actas Españolas de Psiquiatria, 35, 21-28.

De Irala, J., Ruiz-Canela, M., y Martinez-Gonzalez, M. A. (2005). Causal

relationship between cannabis use and psychotic symptoms or depression. Should we wait and see? A public health perspective. Medical Science Monitor, 11, RA355-RA358.

Degenhardt, L., Dierker, L., Chiu, W. T., Medina-Mora, M. E., Neumark,

Y., Sampson, N.,... Kessler, R. C. (2010). Evaluating the drug use “gateway” theory using cross-national data: consistency and associations of the order of initiation of drug use among participants in the WHO World Mental Health Surveys. Drug and Alcohol Dependence, 108, 84-97.

Degenhardt, L., Hall, W., & Lynskey, M. (2003). Exploring the association

between cannabis use and depression. Addiction, 98, 1493-1504.

Delegación del Gobierno para el Plan Nacional sobre Drogas y Ministerio

de Sanidad y Consumo (2006). Cannabis II. Informes de la comisión

clínica. Madrid: Ministerio de Sanidad y Política Social.

Gonzalvo, B., Barral, C., Grau-López, L., Esteve, O., y Roncero, C. (2012).

Comorbilidad psiquiátrica en adolescentes consumidores de cannabis. Trastornos Adictivos, 13, 109-112.

Grant, B. F. & Pickering, R. (1998). The relationship between cannabis

use and DSM-IV cannabis abuse and dependence: results from the National Longitudinal Alcohol Epidemiologic Survey. Journal of Substance Abuse Treatment, 10, 255-264.

Grant, B. F., Stinson, F. S., Dawson, D. A., Chou, S. P., & Ruan, W. J.

(2005). Co-occurrence of DSM-IV personality disorders in the United States: results from the National Epidemiologic Survey on Alcohol and Related Conditions. Comprehensive Psychiatry, 46, 1-5.

Grella, C. E., Hser, Y. I., Joshi, V., & Rounds-Bryant, J. (2001). Drug

treatment outcomes for adolescents with comorbid mental and substance use disorders. Journal of Nervous and Mental Disease, 189, 384-392.

Guillem, E., Pelissolo, A., Vorspan, F., Bouchez-Arbabzadeh, S., y Lépine,

J. P. (2009). Facteurs sociodémographiques, conduites addictives et comorbidité psychiatrique des usagers de cannabis vus en consultation spécialisée. L’Encéphale, 35, 226-233.

Haro, J. M., Alonso, J., Pinto-Meza, A., Vilagut Saiz, G., Fernández, F.,

Codony, M.,…Autonell, J. (2008). The Epidemiology of Mental Disorders in the General Population of Spain. Chapter 19. Part II.

Country-Specific Chapters. In e.Ronald C.Kessler y T.Bedirhan Üstün (Eds.), The WHO World Mental Health Surveys: global Perspectives on the Epidemiology of Mental Disorders. (pp. 406-430). New York: Cambridge University Press.

Hasin, D. S., Trautman, K. D., Miele, G. M., Samet, S., Smith, M., &

Endicott, J. (1996). Psychiatric Research Interview for Substance and Mental Disorders (PRISM): reliability for substance abusers. American Journal of Psychiatry, 153, 1195-1201.

Herrero, M. J., Domingo-Salvany, A., Torrens, M., Brugal, M. T., & the

ITINERE Investigators. (2008). Psychiatric comorbidity in young cocaine users: induced versus independent disorders. Addiction, 103, 284-293.

Lee, S., Tsang, A., Breslau, J., Aguilar-Gaxiola, S., Angermeyer, M., Borges, G.,… Kessler, R. C. (2009). Mental disorders and termination of

education in high-income and low- and middle-income countries:

epidemiological study. British Journal of Psychiatry, 194, 411-417.

Lynskey, M. & Hall W (2000). The effects of adolescent cannabis use on

educational attainment: a review. Addiction, 95, 1621-1630.

Macleod, J. & Hickman, M. (2010). How ideology shapes the evidence

and the policy: what do we know about cannabis use and what should we do? Addiction, 105, 1326-1330.

Martin-Santos, R., Torrens, M., Poudevida, S., Langohr, K., Cuyas, E.,

Pacifici, R.,… de la Torre, R. (2009). 5-HTTLPR polymorphism, mood

disorders and MDMA use in a 3-year follow-up study. Addiction biology, 15, 15-22.

Miller, P. G. & Sonderlund, A. L. (2010). Using the internet to research

hidden populations of illicit drug users: a review. Addiction, 105, 1557-1567.

Moore, T. H., Zammit, S., Lingford-Hughes, A., Barnes, T. R., Jones, P. B.,

Burke, M. & Lewis, G. (2007). Cannabis use and risk of psychotic or

affective mental health outcomes: a systematic review. The Lancet,

, 319-328.

National Survey on Drug Use and Health. (2008). Substance Abuse and Mental Health Services Administration, Office of Applied Studies. Results from the 2007 National Survey on Drug Use and Health: National Findings (NSDUH Series H-34, DHHS Publication No.SMA08-4343). Rockville, MD. Retrived from http://oas.samhsa. gov/nsduh/2k7nsduh/2k7results.cfm.

Nocon, A., Berge, D., Astals, M., Martin-Santos, R., & Torrens, M. (2007).

Dual diagnosis in an inpatient drug-abuse detoxification unit. European Addiction Research, 13, 192-200.

Observatorio Español de Drogas (2009). Informe 2009. Situación y tendencias de los problemas de drogas en España. Madrid: Ministerio de Sanidad y Política Social.

Observatorio Europeo de las Drogas y las Toxicomanías. (2011). Informe

anual 2010. El problema de la drogodependencia en Europa. Luxemburgo: Oficina de Publicaciones de la Unión Europea.

Observatorio Europeo de las Drogas y Toxicomanías (2009). Informe

Anual 2009. El problema de la drogodependencia en Europa. Luxemburgo: Oficina de Publicaciones de la Unión Europea.

Palmer, R. H., Young, S. E., Hopfer, C. J., Corley, R. P., Stallings, M. C.,

Crowley, T. J.,…Hewitt, J. K. (2009). Developmental epidemiology of drug use and abuse in adolescence and young adulthood: Evidence of generalized risk. Drug and Alcohol Dependence, 102, 78-87.

Rodriguez-Llera, M. C., Domingo-Salvany, A., Brugal, M. T., Silva, T. C.,

Sanchez-Niubo, A., & Torrens, M. (2006). Psychiatric comorbidity in young heroin users. Drug and Alcohol Dependence, 84, 48-55.

Roncero, C., Daigre, C., Gonzalvo, B., Valero, S., Castells, X., Grau-Lopez,

L.,… Casas, M. (2011). Risk factors for cocaine-induced psychosis in cocaine-dependent patients. European psychiatry : the journal of the Association of European Psychiatrists. doi.org/10.1016/j.bbr.2011.03.031

Rounsaville, B. J., Kranzler, H. R., Ball, S., Tennen, H., Poling, J., & Triffleman, E. (1998). Personality disorders in substance abusers: relation to substance use. Journal of Nervous and Mental Disease, 186, 87-95.

Skinner, R., Conlon, L., Gibbons, D., & McDonald, C. (2011). Cannabis use and non-clinical dimensions of psychosis in university students presenting to primary care. Acta Psychiatrica Scandinavica, 123, 21-27.

Solowij N, Stephens RS, & Roffman RA (2002). Cognitive functioning of

long-term heavy cannabis users seeking treatment. Journal of the American Medical Association, 287, 1123-1131.

Stinson, F. S., Ruan, W. J., Pickering, R., & Grant, B. F. (2006). Cannabis

use disorders in the USA: prevalence, correlates and co-morbidity.

Psychological Medicine, 36, 1447-1460.

Szerman, N., Arias, F., Vega, P., Babín, F., Mesías, B., Basurte, I.,… Poyo

Calvo, F. (2011). Pilot study on the prevalence of dual pathology in community mental health and substance misuse services in Madrid. Adicciones, 23, 249-255.

Tims, F. M., Dennis, M. L., Hamilton, N., Buchan, J., Diamond, G., Funk, R. & Brantley, L. B. (2002). Characteristics and problems of 600 adolescent cannabis abusers in outpatient treatment. Addiction, 97 Suppl 1, 46-57.

Torrens, M., Serrano, D., Astals, M., Perez-Dominguez, G., & Martin-

Santos, R. (2004). Diagnosing comorbid psychiatric disorders in substance abusers: validity of the Spanish versions of the Psychiatric Research Interview for Substance and Mental Disorders and the Structured Clinical Interview for DSM-IV. American Journal of Psychiatry, 161, 1231-1237.

Veen, N. D., Selten, J. P., van, d. T., I, Feller, W. G., Hoek, H. W., & Kahn, R. S. (2004). Cannabis use and age at onset of schizophrenia. American

Journal of Psychiatry, 161, 501-506.

Weiner, M. D., Sussman, S., McCuller, W. J., & Lichtman, K. (1999). Factors in marijuana cessation among high-risk youth. Journal of Drug Education, 29, 337-357.

Winstock, A. R., Ford, C., & Witton, J. (2010). Assessment and management of cannabis use disorders in primary care. British Medical Journal, 340, c1571.




DOI: https://doi.org/10.20882/adicciones.71

Enlaces refback

  • No hay ningún enlace refback.